| abstract |
The invention provides methods to activate epidermal stem cells and/or progenitor cells by interfering with the JAK/STAT signalling pathway. More specifically, JAK inhibitors are provided for use in epidermal stem cell activation and cosmetic or pharmaceutical applications derived thereof, such as promoting hair growth, treatment of hair-loss disorder, repair and regeneration of the skin. |